BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 3,480.00
-155.00 (-4.26%)
Jun 10, 2026, 3:30 PM KST
BCWORLD PHARM. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2,510 | -4,897 | -4,433 | 2,634 | 281.3 | -1,843 |
Depreciation & Amortization | 8,068 | 7,949 | 7,694 | 7,470 | 7,208 | 5,174 |
Loss (Gain) From Sale of Assets | 104.51 | 137.7 | -20.77 | -48.91 | 0.32 | 0 |
Asset Writedown & Restructuring Costs | - | - | - | - | 64.29 | - |
Loss (Gain) From Sale of Investments | 132.49 | 126.41 | 28.94 | -13.42 | 535.17 | 229.14 |
Stock-Based Compensation | 63.12 | 63.12 | - | - | - | - |
Provision & Write-off of Bad Debts | 148.17 | 461.65 | 55.52 | 223.05 | 34.91 | 49.77 |
Other Operating Activities | 3,450 | 3,259 | 2,068 | 642.45 | -1,251 | -2,522 |
Change in Accounts Receivable | -1,696 | 1,213 | -2,619 | -1,652 | -1,520 | -1,236 |
Change in Inventory | -5,406 | -6,585 | 2,000 | -299.31 | -618.65 | -813.45 |
Change in Accounts Payable | -643.71 | 3,834 | 172.23 | -97.11 | 1,381 | -1,420 |
Change in Unearned Revenue | 21.6 | 9.1 | - | - | - | - |
Change in Other Net Operating Assets | 437.41 | 6.39 | -903.84 | 2,080 | 767.78 | 1,762 |
Operating Cash Flow | 2,170 | 5,577 | 4,042 | 10,938 | 6,883 | -619.83 |
Operating Cash Flow Growth | -65.09% | 37.97% | -63.04% | 58.91% | - | - |
Capital Expenditures | -4,857 | -3,988 | -2,398 | -2,577 | -6,217 | -17,444 |
Sale of Property, Plant & Equipment | 4.73 | 4.73 | 41.93 | 64.27 | 192.36 | 106.58 |
Sale (Purchase) of Intangibles | -395.58 | -17.13 | -9.95 | -132.03 | -47.31 | -1,201 |
Sale (Purchase) of Real Estate | - | - | - | - | -174.45 | -165 |
Investment in Securities | 2,648 | 1,719 | 1,266 | -553.23 | -862.35 | -5.74 |
Other Investing Activities | 67.07 | 67.07 | -38.65 | 81.06 | 431 | 1,020 |
Investing Cash Flow | -2,532 | -2,214 | -1,139 | -3,764 | -6,678 | -17,690 |
Short-Term Debt Issued | - | 30,181 | 22,693 | - | - | - |
Long-Term Debt Issued | - | 12,000 | 8,000 | 35,830 | 35,680 | 30,700 |
Total Debt Issued | 46,181 | 42,181 | 30,693 | 35,830 | 35,680 | 30,700 |
Short-Term Debt Repaid | - | -36,041 | -26,693 | - | - | - |
Long-Term Debt Repaid | - | -8,643 | -7,980 | -39,535 | -32,951 | -19,509 |
Total Debt Repaid | -46,544 | -44,684 | -34,674 | -39,535 | -32,951 | -19,509 |
Net Debt Issued (Repaid) | -362.85 | -2,503 | -3,980 | -3,705 | 2,729 | 11,191 |
Repurchase of Common Stock | -10.88 | -10.88 | - | - | -806.57 | - |
Dividends Paid | -542.73 | -542.73 | -542.73 | -542.73 | -853.86 | -853.86 |
Other Financing Activities | 137.75 | 137.75 | - | -0 | 3.7 | -0 |
Financing Cash Flow | -778.71 | -2,918 | -4,523 | -4,248 | 1,073 | 10,337 |
Foreign Exchange Rate Adjustments | -10.7 | -5.22 | 68.01 | 38.01 | -1.7 | 48.29 |
Net Cash Flow | -1,151 | 439.13 | -1,551 | 2,963 | 1,276 | -7,925 |
Free Cash Flow | -2,687 | 1,589 | 1,644 | 8,361 | 666.21 | -18,064 |
Free Cash Flow Growth | - | -3.36% | -80.33% | 1154.97% | - | - |
Free Cash Flow Margin | -3.37% | 2.10% | 2.20% | 11.13% | 0.92% | -29.10% |
Free Cash Flow Per Share | -290.18 | 171.04 | 177.33 | 818.82 | 64.61 | -1748.42 |
Cash Interest Paid | 3,358 | 3,493 | 4,102 | 4,474 | 2,811 | 1,851 |
Cash Income Tax Paid | 258.01 | 79.78 | 117.07 | -1,291 | -85.77 | 1,100 |
Levered Free Cash Flow | -3,250 | 2,691 | 2,470 | 5,224 | -2,496 | -63,484 |
Unlevered Free Cash Flow | -676.54 | 5,341 | 5,445 | 8,495 | -125.88 | -62,129 |
Change in Working Capital | -7,286 | -1,522 | -1,350 | 31.16 | 9.65 | -1,708 |